A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center

Author(s):
Hosein ali  BasiriHosein ali Basiri1,*, Bahram Fariborz  FarsadBahram Fariborz Farsad1,**
1Iran
Corresponding Authors:

Multidisciplinary Cardiovascular Annals:Vol. 4, issue 2 & 3; e8771
Published online:Jul 25, 2012
Article type:Research Article
Received:Sep 12, 2016
Accepted:Jul 12, 2012

Scheduled for 4 (3)

How to Cite:Basiri HA, Farsad BF. A Randomized Open Blind Control Study Assessing Clopidogrel Resistance in Iranian Patients Undergoing Percutaneous Coronary Intervention in Rajaie Heart Center. Multidiscip Cardio Annal. 2012;4(2):e8771. doi:

Abstract

Fulltext

Full Text Available is PDF

References

  • 1.
    Full Text Available is PDF.

Similar Articles

31
Mar
2013

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention

Mohammad Haji Aghajani,
Farzad Kobarfard,
Olia Safi,
Kourosh Sheibani,
Mohammad Sistanizad

Haji Aghajani M, Kobarfard F, Safi O, Sheibani K, Sistanizad M. Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention. Iran J Pharm Res. 2013;12(Suppl):e125626. doi: https://doi.org/10.22037/ijpr.2013.1283

31
Jul
2018

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention

Mohammad Haji Aghajani,
Farzad Kobarfard,
Seyed pouzhia Shojaei,
Froozan Ahmadpour,
Olia Safi,
Neda Kazemina
,et al.

Haji Aghajani M, Kobarfard F, Shojaei SP, Ahmadpour F, Safi O, et al. The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention. Iran J Pharm Res. 2018;17(3):e124784. doi: https://doi.org/10.22037/ijpr.2018.2259

30
Apr
2020

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention

Soha Namazi,
Ebrahim Sahebi,
Negar Azarpira,
Javad Rostami-Yalmeh,
Javad Kojuri,
Andia Khalili

Namazi S, Sahebi E, Azarpira N, Rostami-Yalmeh J, Kojuri J, et al. Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention. Iran J Pharm Res. 2020;19(2):e124422. doi: https://doi.org/10.22037/ijpr.2020.1101083

20
Oct
2024
Int J Cardiovasc Pract

Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI

Vida Hamrahi,
Mehdi Pishgahi,
Alireza Javan,
Roya Hamrahi,
Mohamad Esmail Ghaidari

Hamrahi V, Pishgahi M, Javan A, Hamrahi R, Ghaidari ME. Comparative Analysis of Ticagrelor and Clopidogrel Effects on Medication Adherence, Adverse Events, and Laboratory Parameters in Iranian Acute Coronary Syndrome Patients Post-PCI. Int J Cardiovasc Pract. 2024;9(2):e150332. doi: https://doi.org/10.5812/intjcardiovascpract-150332

20
Nov
2010

study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of 75 mg of clopidogrel for 7 days

Hamzullah Khan,
Hikmatullah Jan,
Mohammad Hafizullah

Khan H, Jan H, Hafizullah M. study on clopidogrel in inhibition of platelet aggregation in suspected angina patients, treated with a daily dose of 75 mg of clopidogrel for 7 days. Iran J Pharm Res. 2022;8(2):e128628. doi: https://doi.org/10.22037/ijpr.2010.801

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles